Print Page  E-mail Page  RSS  E-mail Alerts  Tearsheet 

SEC Filings

Form SC 14D9
ADVANCED ACCELERATOR APPLICATIONS S.A. filed this Form SC 14D9 on 12/07/2017
Document Outline
Entire Document (1112.5 KB)
Subdocument 1 - SC 14D9 - SC 14D9
Page 1 - SECURITIES AND EXCHANGE COMMISSION
Page 2 - TABLE OF CONTENTS
Page 3 - Item 1. Subject Company Information.
Page 4 - Minimum Condition
Page 5 - Subsequent Offer Period
Page 6 - Treatment of Stock Options and Warrants
Page 7 - Employment Agreements with Executive Officers
Page 8 - Compensation Arrangements Entered Into in Connection with the Offer
Page 9 - Continuing Employee Benefits after the Offer Acceptance Time
Page 10 - Director Resignations
Page 11 - (b) Arrangements with Parent.
Page 12 - Section 12 MoU; Other Agreements
Page 13 - Jefferies
Page 14 - N/A
Page 15 - Second IOI
Page 16 - N/A
Page 17 - N/A
Page 18 - Reasons for the Recommendation
Page 19 - Cash Consideration.
Page 20 - Memorandum of Understanding.
Page 21 - Tender and Support Agreements.
Page 22 - Inability to Solicit Other Takeover Proposals.
Page 23 - (c) Intent to Tender.
Page 24 - (d) Opinion of the Company's Financial Advisor.
Page 25 - N/A
Page 26 - Transaction Overview.
Page 27 - Selected Companies
Page 28 - Enterprise Value/2018 Revenue,
Page 29 - Selected Transactions
Page 30 - Discounted Cash Flow Analysis.
Page 31 - General
Page 32 - Item 6. Interest in Securities of the Subject Company.
Page 33 - Item 4. The Solicitation or Recommendation (c) Intent to Tender
Page 34 - MINEFI
Page 35 - (d) Annual and Current Reports.
Page 36 - N/A
Page 37 - Item 8. Additional Information (g) Forward-Looking Statements
Page 38 - Item 9. Exhibits.
Page 39 - N/A
Page 40 - SIGNATURE
Page 41 - Annex A
Page 42 - N/A
Page 43 - N/A
Subdocument 2 - EX-99.(A)(1)(M) - EX-99.(A)(1)(M)
Page 1 - Exhibit 99.(a)(1)(M)
Page 2 - About Advanced Accelerator Applications S.A.
Page 3 - Cautionary Statement Regarding Forward-Looking Statements
Page 4 - Contacts:
Subdocument 3 - EX-99.(A)(1)(O) - EX-99.(A)(1)(O)
Page 1 - Exhibit 99.(a)(1)(O)
Page 2 - Stock Option Plan
Page 3 - If you OPT for the Cashless Exercise facility
Page 4 - N/A
Page 5 - List of your Stock Options outstanding as of November 20, 2017 which are exercisable under the Offer
Page 6 - ANNEX I - To be completed if you opt for cashless exercise
Page 7 - I hereby declare to exercise my options
Page 8 - Tax Information Notice
Page 9 - ANNEX II To be completed if you do not opt for Cashless Exercise
Page 10 - [Alternative if we do not have the account number for participants before launching the communicatio
Page 11 - if you do not opt for the Cashless Exercise
Page 12 - Share Acceptance Form
Page 13 - PLEASE REVIEW AND COMPLETE (IF NECESSARY) THE FOLLOWING INFORMATION
Page 14 - PLEASE READ THE INSTRUCTIONS ACCOMPANYING THIS ORDINARY SHARE ACCEPTANCE FORM CAREFULLY BEFORE COMPL
Page 15 - INSTRUCTIONS
Subdocument 4 - EX-99.(A)(1)(P) - EX-99.(A)(1)(P)
Page 1 - Exhibit 99.(a)(1)(P)
Page 2 - We recommend that, should you wish (i) to exercise your warrants and participate in the Offer, you s
Page 3 - If you do NOT opt for the Cashless Exercise facility
Page 4 - List of your Warrants outstanding as of November 20, 2017
Page 5 - ANNEX I - To be completed if you opt for cashless exercise
Page 6 - I hereby mandate and instruct Banque Transatlantique S.A. to process the exercise of my warrants, in
Page 7 - All my instructions provided herein become final and irrevocable at the Expiration Date. Until that
Page 8 - [Alternative if we do not have the account number for participants before launching the communicatio
Page 9 - N/A
Page 10 - Share Acceptance Form
Page 11 - PLEASE REVIEW AND COMPLETE (IF NECESSARY) THE FOLLOWING INFORMATION
Page 12 - PLEASE READ THE INSTRUCTIONS ACCOMPANYING THIS ORDINARY SHARE ACCEPTANCE FORM CAREFULLY BEFORE COMPL
Page 13 - INSTRUCTIONS
Subdocument 5 - EX-99.(A)(1)(Q) - EX-99.(A)(1)(Q)
Page 1 - Exhibit 99.(a)(1)(Q)
Page 2 - Price per Ordinary Share, i.e U.S. $41.00, for each Non-Vested Free Share waived
Page 3 - Your Non-Vested Free Shares as of November 20, 2017 to the extent they remain outstanding as of Dece
Page 4 - Waiver of your rights to Non-Vested Free Shares
Page 5 - gross
Subdocument 6 - EX-99.(A)(1)(R) - EX-99.(A)(1)(R)
Page 1 - Exhibit 99.(a)(1)(R)
Subdocument 7 - EX-99.(E)(2) - EX-99.(E)(2)
Page 1 - Exhibit 99.(e)(2)
Page 2 - Section 2.2.4
Page 3 - Section 2.5.3
Page 4 - N/A
Page 5 - ACKNOWLEDGED AND AGREED TO: NOVARTIS AG By: /s/ Augusto Lima Name: Augusto Lima Title: As Attorney B
Subdocument 8 - EX-99.(E)(4) - EX-99.(E)(4)
Page 1 - Exhibit 99.(e)(4)
Page 2 - Subject Securities
Page 3 - Return of Subject Securities
Page 4 - Non-Contravention; Consents
Page 5 - SECTION 6. REPRESENTATIONS AND WARRANTIES OF PARENT
Page 6 - directeur g n ral
Page 7 - New Board Members
Page 8 - SECTION 9. MISCELLANEOUS
Page 9 - vice versa
Page 10 - Governing Law
Page 11 - N/A
Page 12 - N/A
Page 13 - Exhibit A
Page 14 - Exhibit B
Page 15 - directeur g n ral
Subdocument 9 - EX-99.(E)(5) - EX-99.(E)(5)
Page 1 - Exhibit 99.(e)(5)
Page 2 - Exhibit A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - ACKNOWLEDGED AND AGREED TO: NOVARTIS AG By: /s/ Augusto Lima Name: Augusto Lima Title: As Attorney B
Subdocument 10 - EX-99.(E)(11) - EX-99.(E)(11)
Page 1 - Exhibit 99.(e)(11)
Page 2 - Base Salary
Page 3 - Other Benefits Plans
Page 4 - Termination by the Company for Cause
Page 5 - Termination by the Executive Without Good Reason
Page 6 - Payment of Unpaid Base Salary
Page 7 - Exchange Act
Page 8 - Scope
Page 9 - N/A
Page 10 - provided
Page 11 - provided, however,
Page 12 - N/A
Page 13 - In Witness Whereof,
Subdocument 11 - EX-99.(E)(12) - EX-99.(E)(12)
Page 1 - Exhibit 99.(e)(12)
Page 2 - Base Salary
Page 3 - Other Benefits Plans
Page 4 - Disability
Page 5 - Termination by the Executive for Good Reason
Page 6 - Payment of Unpaid Base Salary
Page 7 - Exchange Act
Page 8 - Scope
Page 9 - provided, however,
Page 10 - N/A
Page 11 - In Witness Whereof
Subdocument 12 - EX-99.(E)(13) - EX-99.(E)(13)
Page 1 - Exhibit 99.(e)(13)
Page 2 - Base Salary
Page 3 - Other Benefits Plans
Page 4 - Disability
Page 5 - Termination by the Executive for Good Reason
Page 6 - Payment of Unpaid Base Salary
Page 7 - Exchange Act
Page 8 - Scope
Page 9 - provided, however,
Page 10 - N/A
Page 11 - In Witness Whereof
Subdocument 13 - EX-99.(E)(14) - EX-99.(E)(14)
Page 1 - Exhibit 99.(e)(14)
Page 2 - Exhibit A
Page 3 - N/A
Page 4 - EXHIBIT A
Page 5 - or otherwise, to terminate the employment or engagement with Novartis, nor shall you directly or ind
Subdocument 14 - EX-99.(E)(15) - EX-99.(E)(15)
Page 1 - Exhibit 99.(e)(15)
Page 2 - Remainder of page intentionally left blank; signature page follows
Page 3 - [Signature Page for BER Letter]
Page 4 - EXHIBIT A
Page 5 - or otherwise, to terminate the employment or engagement with Novartis, nor shall you directly or ind